Author

Yuki Takeuchi

Institution: Nagoya University

Observed institution: Nagoya University

ORCID: 0009-0003-9021-5549

Observed ORCID: 0009-0003-9021-5549

OpenAlex ID: A5038733228

Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway

2024 · Yoshitaka Adachi, Seitaro Terakura, et al. · Nature Communications · 22

Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2023 · Kanae Imai, Yuki Takeuchi, et al. · Molecular Cancer Therapeutics · 19

Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells

2025 · Masahide Osaki, Seitaro Terakura, et al. · Journal for ImmunoTherapy of Cancer · 2

CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis

2026 · Yuki Takeuchi, Seitaro Terakura, et al. · Journal for ImmunoTherapy of Cancer · 1

BATF3 regulates differentiation of CD8 + T lymphocytes and memory differentiation program

2026 · Koji Umemura, Yasuhiro Kojima, et al. · Life Science Alliance

Supplementary FIgure S2 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Supplementary Figure S1 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Supplementary Figure S1 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Data from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Data from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Supplementary Figure S3 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Supplementary Figure S3 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Supplementary FIgure S2 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

2024 · Kanae Imai, Yuki Takeuchi, et al.

Analysis of Metabolic Mechanism of CD19CAR-T with CD79A/CD40 Co-Stimulatory Domain Based on Comparison with Established CAR-Ts

2023 · Yuki Takeuchi, Seitaro Terakura, et al. · Blood

Works count: 14

Citation count: 44

H-index: 2

I10-index: 2